Go back to Resource Center
Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss
27/09/2005
Conference Paper
Authors:
Aiello, L.P.;
Vignati, L.;
Sheetz, M.J.;
Zhi, X.;
Girach, A.;
Davis, M.D.;
Milton, R.C.;
Group, T.P.K.C.D.R.S.2 S.
Secondary:
13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG)
Location: Berlin, Germany
URL:
http://www.dog2005.org/images/soe_dog_programme_2005.pdf
